Top Markets
Coin of the day
Medivir AB (publ) Medivir AB (publ)

Medivir AB (publ)

MVIR-B
Rang în acțiuni #29651
Medivir AB (publ) is a pharmaceutical company established in 1987 and... Medivir AB (publ) is a pharmaceutical company established in 1987 and headquartered in Huddinge, Sweden. It is dedicated to the research, development, and global commercialization of medicines, with a primary focus on oncology. The company currently markets Zoviduo (formerly Xerclear) for the treatment of labial herpes. Its robust development pipeline includes Remetinostat, targeting MF cutaneous T-cell lymphoma and basal cell carcinoma; MIV-818, aimed at liver cancer; and MIV-711, being advanced for osteoarthritis. Additionally, Medivir is progressing Birinapant and IGM-8444 for various solid tumor indications. Collaborative efforts are also key to its strategy, including a research partnership with SciLifeLab's Drug Discovery and Development Platform to discover antivirals for SARS CoV-2, alongside licensing agreements with Tango Therapeutics for a preclinical research program and with Ubiquigent Limited for the USP7 preclinical research program.
Preț acțiune
$0.68377137
Ultima sincronizare: 2023-05-23
Capitalizare de piață
$20.23M
Schimbare (1 zi)
-0.60%
Schimbare (1 an)
0.00%
Țară
SE
Tranzacționează Medivir AB (publ) (MVIR-B)

Categorie

Istoricul spliturilor pentru Medivir AB (publ) (MVIR-B)
Acțiunea Medivir AB (publ) (simbol: MVIR-B) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Aug 19, 2026.
O acțiune MVIR-B cumpărată înainte de Aug 19, 2026 este echivalentă astăzi cu 0 acțiuni MVIR-B.
Listă splituri acțiuni
An Split Multiplu Multiplu cumulativ
Nu sunt suficiente date pentru perioada selectată.
Splituri pentru companii similare sau competitori
Companie Număr total de splituri Multiplu cumulativ Țara
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
KR